| Revised international prognostic scoring system for myelodysplastic syndromes PL Greenberg, H Tuechler, J Schanz, G Sanz, G Garcia-Manero, F Solé, ... Blood, The Journal of the American Society of Hematology 120 (12), 2454-2465, 2012 | 3362 | 2012 |
| Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 M Ko, Y Huang, AM Jankowska, UJ Pape, M Tahiliani, HS Bandukwala, ... Nature 468 (7325), 839-843, 2010 | 1500 | 2010 |
| The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria P Hillmen, NS Young, J Schubert, RA Brodsky, G Socié, P Muus, A Röth, ... New England Journal of Medicine 355 (12), 1233-1243, 2006 | 1440 | 2006 |
| Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia HLM Koskela, S Eldfors, P Ellonen, AJ van Adrichem, H Kuusanmäki, ... New England Journal of Medicine 366 (20), 1905-1913, 2012 | 859 | 2012 |
| The pathophysiology of acquired aplastic anemia NS Young, J Maciejewski New England journal of medicine 336 (19), 1365-1372, 1997 | 725 | 1997 |
| Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria RA Brodsky, NS Young, E Antonioli, AM Risitano, H Schrezenmeier, ... Blood, The Journal of the American Society of Hematology 111 (4), 1840-1847, 2008 | 714 | 2008 |
| Somatic mutations and clonal hematopoiesis in aplastic anemia T Yoshizato, B Dumitriu, K Hosokawa, H Makishima, K Yoshida, ... New England Journal of Medicine 373 (1), 35-47, 2015 | 646 | 2015 |
| Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in … J Maciejewski, C Selleri, S Anderson, NS Young | 626 | 1995 |
| Aberrant DNA methylation is a dominant mechanism in MDS progression to AML Y Jiang, A Dunbar, LP Gondek, S Mohan, M Rataul, C O'Keefe, ... Blood, The Journal of the American Society of Hematology 113 (6), 1315-1325, 2009 | 528 | 2009 |
| Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis H Makishima, V Visconte, H Sakaguchi, AM Jankowska, S Abu Kar, ... Blood, The Journal of the American Society of Hematology 119 (14), 3203-3210, 2012 | 485 | 2012 |
| Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms AM Jankowska, H Szpurka, RV Tiu, H Makishima, M Afable, J Huh, ... Blood, The Journal of the American Society of Hematology 113 (25), 6403-6410, 2009 | 457 | 2009 |
| STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia A Jerez, MJ Clemente, H Makishima, H Koskela, F LeBlanc, K Peng Ng, ... Blood, The Journal of the American Society of Hematology 120 (15), 3048-3057, 2012 | 448 | 2012 |
| Inherited and somatic defects in DDX41 in myeloid neoplasms C Polprasert, I Schulze, MA Sekeres, H Makishima, B Przychodzen, ... Cancer cell 27 (5), 658-670, 2015 | 441 | 2015 |
| Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria P Hillmen, P Muus, A Röth, MO Elebute, AM Risitano, H Schrezenmeier, ... British journal of haematology 162 (1), 62-73, 2013 | 439 | 2013 |
| Dynamics of clonal evolution in myelodysplastic syndromes H Makishima, T Yoshizato, K Yoshida, MA Sekeres, T Radivoyevitch, ... Nature genetics 49 (2), 204-212, 2017 | 432 | 2017 |
| Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents MW Wlodarski, S Hirabayashi, V Pastor, J Starý, H Hasle, R Masetti, ... Blood, The Journal of the American Society of Hematology 127 (11), 1387-1397, 2016 | 409 | 2016 |
| Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML LP Gondek, R Tiu, CL O'Keefe, MA Sekeres, KS Theil, JP Maciejewski Blood, The Journal of the American Society of Hematology 111 (3), 1534-1542, 2008 | 405 | 2008 |
| HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome Y Saunthararajah, R Nakamura, JM Nam, J Robyn, F Loberiza, ... Blood, The Journal of the American Society of Hematology 100 (5), 1570-1574, 2002 | 376 | 2002 |
| Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A AM Jankowska, H Makishima, RV Tiu, H Szpurka, Y Huang, F Traina, ... Blood, The Journal of the American Society of Hematology 118 (14), 3932-3941, 2011 | 368 | 2011 |
| Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms F Traina, V Visconte, P Elson, A Tabarroki, AM Jankowska, E Hasrouni, ... Leukemia 28 (1), 78-87, 2014 | 366 | 2014 |
